ANTERIS TECHNOLOGIES GLOBAL CORP.
6.85AUDD
+0.01+0.15%
At close at May 16, 05:33 GMT
AUD
No trades
Next report date
≈
August 21
Report period
H1 2025
EPS estimate
−1.26 AUD
Revenue estimate
4.00 M AUD
−67.33 M AUD
4.11 M AUD
33.91 M
About ANTERIS TECHNOLOGIES GLOBAL CORP.
Sector
Industry
CEO
Wayne Geoffrey Paterson
Website
Headquarters
Toowong
Founded
1999
ISIN
AU0000088841
FIGI
BBG01PLXJ6N8
Anteris Technologies Ltd. is a structural heart company, which engages in research, develops, commercializes, and distributes medical technologies and devices. It operates through the following geographical segments: Australia, United States, and Switzerland. It manufactures, distributes, and sells ADAPT and DurAVR regenerative tissue products, and researches and develops regenerative medicine and immunotherapies. The company was founded on June 23, 1999 and is headquartered in Toowong, Australia.
−2,600.0%
−2,200.0%
−1,800.0%
−1,400.0%
−1,000.0%
H2 '22
H1 '23
H2 '23
H1 '24
−51.00 M
−34.00 M
−17.00 M
0.00
17.00 M
Revenue
Net income
Net margin %
No data available
There's currently no revenue data to show for the selected period.
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
−50.00 M
−25.00 M
0.00
25.00 M
50.00 M
Debt
Free cash flow
Cash & equivalents
No news here
Looks like there's nothing to report right now
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.